BioCorRx (BICX) Convertible Debt (2012 - 2019)

BioCorRx has disclosed Convertible Debt across 7 years of filings, most recently posting $4.2 million for Q4 2019.

• Convertible Debt for Q4 2019 came in at $4.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $4.2 million (changed N/A YoY), and the FY2019 annual result was $4.2 million, changed N/A from the prior year.
• Convertible Debt came in at $4.2 million for Q4 2019 at BioCorRx, roughly flat from $4.2 million in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $4.2 million in Q3 2019 to a low of $685.0 in Q3 2015.
• The 5-year median for Convertible Debt is $791966.0 (2016), against an average of $1.3 million.
• Across the five-year window, Convertible Debt soared 73150.51% in 2016 and surged 166.2% in 2018, its largest moves.
• BioCorRx's Convertible Debt stood at $5530.0 in 2015, then surged by 12355.39% to $688783.0 in 2016, then surged by 192.7% to $2.0 million in 2017, then increased by 18.2% to $2.4 million in 2018, then jumped by 74.58% to $4.2 million in 2019.
• The last three Convertible Debt figures came in at $4.2 million (Q4 2019), $4.2 million (Q3 2019), and $2.4 million (Q1 2018), per Business Quant data.